Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1441 AL 1455

AD biomarker discovery in CSF and in alternative matrices

Sancesario G, Bernardini S.

Clin Biochem. 2019 Oct;72:52-57. doi: 10.1016/j.clinbiochem.2019.08.008. Epub 2019 Aug 19.

Role of miRNAs in Alzheimer's Disease and Possible Fields of Application

Silvestro S, Bramanti P, Mazzon E.

Int J Mol Sci. 2019 Aug 15;20(16):3979. doi: 10.3390/ijms20163979.

A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment

Mavroudis IA, Petridis F, Chatzikonstantinou S, Kazis D.

Aging Clin Exp Res. 2020 Sep;32(9):1639-1646. doi: 10.1007/s40520-019-01326-z. Epub 2019 Aug 28.

The "rights" of precision drug development for Alzheimer's disease

Cummings J, Feldman HH, Scheltens P.

Alzheimers Res Ther. 2019 Aug 31;11(1):76. doi: 10.1186/s13195-019-0529-5.

Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions

Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE.

J Alzheimers Dis. 2019;71(3):715-732. doi: 10.3233/JAD-190507.

Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment

Falgàs N, Sánchez-Valle R, Bargalló N, Balasa M, Fernández-Villullas G, Bosch B, Olives J, Tort-Merino A, Antonell A, Muñoz-García C, León M, Grau O, Castellví M, Coll-Padrós N, Rami L, Redolfi A, Lladó A.

Neuroimage Clin. 2019;23:101927. doi: 10.1016/j.nicl.2019.101927. Epub 2019 Jul 5.

Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid

Takousis P, Sadlon A, Schulz J, Wohlers I, Dobricic V, Middleton L, Lill CM, Perneczky R, Bertram L.

Alzheimers Dement. 2019 Nov;15(11):1468-1477. doi: 10.1016/j.jalz.2019.06.4952. Epub 2019 Sep 5.

A Pilot Study of Exenatide Actions in Alzheimer's Disease

Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, Li Y, Mattson MP, Resnick S, Egan JM, Greig NH, Kapogiannis D.

Curr Alzheimer Res. 2019;16(8):741-752. doi: 10.2174/1567205016666190913155950.

Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis

Xie B, Zhou H, Liu W, Yu W, Liu Z, Jiang L, Zhang R, Cui D, Shi Z, Xu S.

Int J Neurosci. 2020 Mar;130(3):218-230. doi: 10.1080/00207454.2019.1667794. Epub 2019 Sep 24.

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

Chandra A, Valkimadi PE, Pagano G, Cousins O, Dervenoulas G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442. doi: 10.1002/hbm.24782. Epub 2019 Sep 14.

A New Discovery of MicroRNA-455-3p in Alzheimer's Disease

Kumar S, Reddy PH.

J Alzheimers Dis. 2019;72(s1):S117-S130. doi: 10.3233/JAD-190583.

Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review

Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P.

Neurosci Biobehav Rev. 2019 Dec;107:346-359. doi: 10.1016/j.neubiorev.2019.09.014. Epub 2019 Sep 13.

Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease

Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, Sylvestre JP, Rosa-Neto P, Mathotaarachchi S, Gauthier S, Nasreddine ZS, Arbour JD, Rhéaume MA, Beaulieu S, Dirani M, Nguyen CTO, Bui BV, Williamson R, Crowston JG, van Wijngaarden P.

Nat Commun. 2019 Sep 17;10(1):4227. doi: 10.1038/s41467-019-12242-1.

Alzheimer's disease in aging Down syndrome

Cohen AD, Head E, Lee JH.

Dev Neurobiol. 2019 Jul;79(7):611-612. doi: 10.1002/dneu.22717.

Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL.

J Geriatr Psychiatry Neurol. 2020 Jul;33(4):175-184. doi: 10.1177/0891988719874118. Epub 2019 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias